Cargando…
Number of Patients Studied Prior to Approval of New Medicines: A Database Analysis
BACKGROUND: At the time of approval of a new medicine, there are few long-term data on the medicine's benefit–risk balance. Clinical trials are designed to demonstrate efficacy, but have major limitations with regard to safety in terms of patient exposure and length of follow-up. This study of...
Autores principales: | Duijnhoven, Ruben G., Straus, Sabine M. J. M., Raine, June M., de Boer, Anthonius, Hoes, Arno W., De Bruin, Marie L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601954/ https://www.ncbi.nlm.nih.gov/pubmed/23526887 http://dx.doi.org/10.1371/journal.pmed.1001407 |
Ejemplares similares
-
Resting Heart Rate Is a Risk Factor for Mortality in Chronic Obstructive Pulmonary Disease, but Not for Exacerbations or Pneumonia
por: Warnier, Miriam J., et al.
Publicado: (2014) -
Improving the Safety of Medicines in the European Union: From Signals to Action
por: Potts, Joanne, et al.
Publicado: (2019) -
Room for Improvement in Conducting and Reporting Non-Inferiority Randomized Controlled Trials on Drugs: A Systematic Review
por: Wangge, Grace, et al.
Publicado: (2010) -
Increased Risk of Sudden Cardiac Arrest in Obstructive Pulmonary Disease: A Case-Control Study
por: Warnier, Miriam Jacoba, et al.
Publicado: (2013) -
Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs
por: Mazzaglia, Giampiero, et al.
Publicado: (2017)